Catalyst Wire Dossier Catalyst Wire Dossier

Investigational obesity drug

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational obesity drug, covering 2015-03-13 to 2015-03-13. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED) [Phase 3]

See pricing